Search results
What Is the First Line of Treatment for Multiple Sclerosis?
Verywell Health via Yahoo News· 2 years agoMedically reviewed by Lindsay Cook, PharmD In multiple sclerosis (MS), the immune system attacks the...
Experimental Therapies for Multiple Sclerosis (MS)
Verywell Health via Yahoo News· 2 years agoThe goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. This article reviews the latest...
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
Benzinga via Yahoo Finance· 11 months agoRoche Holdings AG's (OTC: RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus (ocrelizumab) as a...
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
Investor's Business Daily· 11 months agoRoche unveiled positive results Thursday for a rival to TG Therapeutics' one-hour infusion for...
Halozyme (HALO) Rises 5% as Ocrevus SC Meets Goals in MS Study
Zacks via Yahoo Finance· 11 months agoHalozyme (HALO) rises 5% after Roche's late-stage multiple sclerosis study of subcutaneous...
What is multiple sclerosis? Why MS is behind Selma Blair's "DWTS" departure
CBS News via Yahoo News· 2 years agoSelma Blair revealed this week she was leaving "Dancing with the Stars" due to complications from...
Roche sales decline more than expected as COVID products slide
Reuters via Yahoo Finance· 2 years ago(Reuters) -Roche's quarterly sales declined 6% as a slump in COVID-19 treatments and diagnostic...
Roche (RHHBY) Q3 Revenues Dip on Lower COVID-19-Related Sales
Zacks via Yahoo Finance· 2 years agoSwiss pharma giant Roche Holding AG’s RHHBY third-quarter revenues declined 6% to CHF 14.7 billion...
Top-Notch Biotech TG Therapeutics Breaks Out On 'Solid Jump' In Sales
Investor's Business Daily· 1 year agoTG Therapeutics' new multiple sclerosis drug, Briumvi, experienced a "solid jump" in March sales,...
Roche's (RHHBY) MS Drug Reduces Brain Lesions in Phase II Study
Zacks via Yahoo Finance· 8 months agoRoche (RHHBY) presents new data from a phase II study, which shows that fenebrutinib is brain...